Surface activation of factor XII (Hageman factor) — Critical role of high molecular weight kininogen and another potentiator
- 1 January 1978
- journal article
- histamine and-kinins
- Published by Springer Nature in Inflammation Research
- Vol. 8 (1-2) , 65-72
- https://doi.org/10.1007/bf01972404
Abstract
When factor XII was adsorbed to kaolin it slowly became activated and converted prekallikrein to kallikrein. In the presence of HMW-kininogen the rate of activation of factor XII and consequently that of prekallikrein was markedly enhanced. The enhancing effect of HMW-kininogen was a dose-dependent phenomenon. In order to enhance the activation of factor XII on a surface the HMW-kininogen molecule had to be intact. Cleavage of HMW-kininogen by kallikrein decreased the enhancing effect of HMW-kininogen, there being an inverse relation between the bradykinin-generated and the capacity to enhance factor XII activation. Another ‘potentiator’ of factor XII activation was isolated from proteins adsorbed to aluminum hydroxide. This potentiator further increased the activation of factor XII, also in a dose-dependent fashion. It was postulated that factor XII is slowly converted into its active form by exposure to negatively charged surfaces; that this process is enhanced by kallikrein and further accelerated by HMW-kininogen and the ‘potentiator’; and that these enhancing substances probably act by opening active sites on the factor XII molecule.Keywords
This publication has 30 references indexed in Scilit:
- Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.Journal of Clinical Investigation, 1976
- Rapid purification of human high molecular weight kininogenInflammation Research, 1976
- Flaujeac trait. Deficiency of human plasma kininogen.Journal of Clinical Investigation, 1975
- Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.Journal of Clinical Investigation, 1975
- Partial purification and characterization of contact activation cofactor.Journal of Clinical Investigation, 1975
- The Secondary Structure of Human Hageman Factor (Factor XII) and its Alteration by Activating AgentsJournal of Clinical Investigation, 1974
- Preparation, Characterization, and Activation of a Highly Purified Factor XI: Evidence that a Hitherto Unrecognized Plasma Activity Participates in the Interaction of Factors XI and XIIBritish Journal of Haematology, 1974
- Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.Journal of Clinical Investigation, 1974
- PREKALLIKREIN DEFICIENCY IN MANThe Journal of Experimental Medicine, 1973
- A PREALBUMIN ACTIVATOR OF PREKALLIKREINThe Journal of Experimental Medicine, 1971